RecruitingEarly Phase 1NCT06345833

Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

Studying Hemophilia A

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Minnesota
Principal Investigator
Jenna Van Beck, MD
University of Minnesota
Intervention
1%Tranexamic acid with standard local(drug)
Enrollment
50 target
Eligibility
18 years · All sexes
Timeline
20242026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06345833 on ClinicalTrials.gov

Other trials for Hemophilia A

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia A

← Back to all trials